Sydney, June 23, 2026, 06:07 AEST
- Xero closed Monday at A$68.62, down 4.54%, for its first sub-A$70 finish since 2022.
- WiseTech’s 18% plunge and likely financial-year-end selling amplified the sector move; Xero issued no fresh trading update.
- Australian subscription prices rise by 4% to 12.6% from July 1, offering an overlooked revenue lever but raising churn risk.
Xero Ltd (ASX:XRO) fell A$3.26 to A$68.62 on Monday, a 4.54% drop that left the cloud-accounting stock at its session low. It broke A$70 in the final half-hour and recorded its first close below that level since 2022. The ASX information technology index lost 4.2%, against a 0.14% decline for the broader S&P/ASX 200.
The immediate trigger looked like a sector shock rather than a new assessment of Xero’s operations. WiseTech Global (ASX:WTC) sank more than 18% after reports that Australian Federal Police were investigating executive chairman Richard White. Reuters could not independently verify the reports, while WiseTech declined to comment. No fresh Xero earnings or trading update accompanied the fall; its public media-release list was last updated on June 18.
That distinction matters before Tuesday’s Australian open. U.S. software shares were trading at a more than two-month low late on Monday as Alphabet and other large technology stocks retreated. “This is a very sentiment-driven sector and the group tends to trade together on a day-to-day basis,” said Bill Northey, senior investment director at U.S. Bank. Reuters
One plausible amplifier is tax-loss selling — disposing of a losing investment so its capital loss can offset taxable gains. Xero has fallen 64.6% in 12 months, making it an obvious candidate for such portfolio clearing ahead of Australia’s June 30 financial-year end. That does not prove a particular fund sold for tax reasons, but it suggests part of Monday’s supply may have been insensitive to Xero’s current valuation.
Index mechanics can add another layer. Betashares has noted that Xero and WiseTech both carry high weights in the ASX information technology index. When investors cut sector exposure, a shock in one large constituent can therefore pull the other lower through index funds and technology baskets, even without company-specific news. That mechanism fits Monday’s unusually wide gap between the technology sector and the broader market.
The less visible company catalyst arrives on July 1. Xero will increase Australian monthly subscription prices by about 4% to 7% on its Ignite, Grow and Comprehensive plans, while several Ultimate plans rise by 10% to 12.6%. The company will also remove its multi-organisation discount for eligible subscriptions.
The increases matter because Australia and New Zealand produced NZ$1.4 billion, roughly half of Xero’s NZ$2.75 billion in FY26 revenue. Average revenue per customer, or ARPC, rose 17% in the region to NZ$48.89. Although Australia represents only part of that regional total, the new pricing gives Xero a direct route to further ARPC growth without first winning additional customers. FY26 group revenue rose 31% and adjusted EBITDA — operating earnings before interest, tax, depreciation and amortisation, excluding selected items — increased 18%, while net profit fell 27% as Melio-related costs weighed.
Fund managers remain divided over whether Melio’s payments exposure justifies those costs. James Gerrish of Market Partners recently rated Xero a buy, though with less conviction than Pro Medicus, and said the acquisition had been made at the wrong time and at too high a price. Still, he argued: “Accounting software is a good business, but payments are a better business.” Ten Cap’s Jun Bei Liu rated Xero a hold, saying AI will change accounting workflows but regulatory checks and customer trust still protect established platforms. Livewire Markets
But list-price increases do not translate dollar-for-dollar into revenue. Discounts, customer mix and cancellations can dilute the benefit, particularly if small businesses resist another cost increase. Xero must also integrate Melio while spending up to an additional NZ$55 million on its U.S. brand in FY27. Management expects adjusted EBITDA to be weighted more heavily than usual toward the second half, increasing the damage an early execution miss could cause.
The near-term test is whether Xero can recover A$70 as June 30 passes. A quick rebound would support the view that basket selling and tax-year positioning exaggerated Monday’s decline. Continued weakness after those flows ease would suggest investors remain more concerned about Melio, AI competition and earnings quality than the July pricing lift.
